"Spear Bio Raises $45M in Series A Funding to Expand Assay Menu and Accelerate Commercial Offerings"

Spear Bio Inc. raises $45M in Series A Funding

Spear Bio (Linkedin), a biotechnology research company based in the United States, recently secured $45 million in Series A funding to expand their assay menu and advance their protein biomarker measurement technology. They are poised to revolutionize protein research and early disease diagnostics in the biotech and pharmaceutical industries.

Funding Amount: $45 million

Industry: Biotechnology Research

Employee Count: 11-50

CEO: Jerome Clavel (CEO Linkedin)

What Spear Bio needs to buy: Research institutions, biotech companies, diagnostic laboratories, and protein research and diagnostic equipment providers are ideal partners for Spear Bio. These companies can support Spear Bio in further developing their protein biomarker measurement technology, scaling up production, and expanding their market reach through targeted marketing and sales efforts.